title: Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone.
authors.affiliation: Department of Molecular and Clinical Oncology and Endocrinology, School of Medicine, Federico II University, Naples, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Palmieri
authors.forename: S
authors.initials: S
authors.lastname: Lastoria
authors.forename: A
authors.initials: A
authors.lastname: Colao
authors.forename: E
authors.initials: E
authors.lastname: Vergara
authors.forename: P
authors.initials: P
authors.lastname: Varrella
authors.forename: E
authors.initials: E
authors.lastname: Biondi
authors.forename: C
authors.initials: C
authors.lastname: Selleri
authors.forename: L
authors.initials: L
authors.lastname: Catalano
authors.forename: G
authors.initials: G
authors.lastname: Lombardi
authors.forename: A R
authors.initials: AR
authors.lastname: Bianco
authors.forename: M
authors.initials: M
authors.lastname: Salvatore
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D012010:Red-Cell Aplasia, Pure / Q000150:complications / Q000188:drug therapy*; D013945:Thymoma / Q000150:complications / Q000188:drug therapy*; D013953:Thymus Neoplasms / Q000150:complications / Q000188:drug therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D005938:Glucocorticoids; D015282:Octreotide; D011241:Prednisone